Analyst Price Targets — AVAH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 28, 2026 8:50 am | — | Barclays | $15.00 | $13.82 | TheFly | Aveanna price target raised to $15 from $9.50 at Barclays |
| August 24, 2026 12:25 pm | — | Truist Financial | $15.00 | $13.81 | TheFly | Aveanna price target raised to $15 from $11 at Truist |
| August 21, 2026 8:49 pm | — | RBC Capital | $16.00 | $13.16 | TheFly | Aveanna price target raised to $16 from $10 at RBC Capital |
| August 14, 2026 12:29 pm | — | Deutsche Bank | $16.00 | $11.87 | TheFly | Aveanna price target raised to $16 from $11.50 at Deutsche Bank |
| August 14, 2026 12:23 pm | — | UBS | $13.00 | $11.80 | TheFly | Aveanna price target raised to $13 from $8 at UBS |
| August 14, 2026 11:25 am | — | BMO Capital | $14.00 | $11.29 | TheFly | Aveanna price target raised to $14 from $10 at BMO Capital |
| August 14, 2026 10:07 am | John Ransom | Raymond James | $15.00 | $11.29 | StreetInsider | Aveanna Healthcare Holdings Inc (AVAH) PT Raised to $15 at Raymond James |
| July 14, 2026 11:50 am | — | Truist Financial | $11.00 | $9.67 | TheFly | Aveanna price target raised to $11 from $9 at Truist |
| July 8, 2026 10:19 am | — | Barclays | $9.50 | $9.60 | TheFly | Aveanna price target raised to $9.50 from $9 at Barclays |
| May 20, 2026 11:48 am | David MacDonald | Truist Financial | $9.00 | $7.63 | TheFly | Aveanna price target raised to $9 from $8 at Truist |
Latest News for AVAH
Canada Pension Plan Investment Board bought a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 87,800 shares of the company's stock, valued at approximately $752,000. Other hedge funds and other institutional investors also
Aveanna Healthcare Holdings demonstrates strong revenue and earnings growth, with a focus on private duty services and strategic M&A. AVAH trades at a low LTM P/E of 11.8x, reflecting its high leverage but also offering compelling value versus peers. Management targets reducing leverage below 3x, prioritizing cash-funded acquisitions and disciplined expansion to mitigate balance sheet risks.
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVAH.
U.S. House Trading
No House trades found for AVAH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.